HACCP/ISO22000认证问题及分析-显著危害和关键限值（CL）不明确
HACCP / ISO22000 certification and analysis of significant hazards and critical limit ( CL ) are not clear
显著危害和关键限值（CL）不明确
Significant hazards and critical limit ( CL ) are not clear
例子：XX饮料有限公司饮料生产中原（辅）料接收工序（CCP1）“药物残留”这一显著危害及其关键限值（见第6页XX饮料HACCP计划表）
Examples: XX limited company of beverage of beverage production Central Plains ( auxiliary ) material receiving process ( CCP1 )" drug residues" this significant hazards and critical limit ( see page sixth XX. HACCP schedule )
分析：
Analysis.
CAC《HACCP体系及其应用准则》规定：“关键限值是区分可接受与不可接受水平的指标，对每个关键控制点必须规定关键限值，并予以确认，在某些情况下和某一特定步骤中，要对一个以上的关键限值作详细说明。”
CAC" HACCP system and guidelines for its application" stipulates:" the key limit value is to distinguish between acceptable and unacceptable levels of indexes, for each critical control points critical limits must be specified, and affirming that, in some cases and a particular step, to a more detailed description of key limit value."
XX饮料有限公司饮料生产HACCP计划中，原（辅）料接收工序（CCP1）把药物残留作为显著危害，关键限值是供货商提供卫生合格证明或合格的检测报告(进口原料保留商检局检验分析报告)。
XX HACCP limited company of beverage of beverage production plan, raw ( auxiliary ) material receiving process ( CCP1 ) to drug residue as a significant hazard, critical limits is the supplier to provide a health certificate or qualification test report ( imported raw materials reservation Commodity Inspection Bureau test analysis report ).
这里，既无明确那一种药物的残留是显著危害，也没有规定出每一种药物的最大残留量作为其关键限值，CCP的控制对象和控制标准均不明确，导致这个CCP形同虚设。
Here, there is no clear that a drug residues is significant, there is no provision for each drug maximum residue limits of CCP as its key, the control object and control standard are not clear, cause the CCP exists in name only.
应当根据危害分析的结果，明确列出属于显著危害的药物名称，并明确列出每一种药物的允许最大残留量作为关键限值。
Should be based on the hazard analysis results, explicitly listed as belonging to the significant hazards of drug names, and explicitly lists every drug allows maximum residue limit value as the key.